C

CStone Pharmaceuticals
2616

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
HK$14.65B
EV
HK$14.32B
Shares Outstanding
1.46B
Beta
0.04

Wall Street View

Analyst Rating
BUY
Analyst Target Price
HK$8.62
P/E 2025E
-
P/Revenue 2025E
109.44x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About CStone Pharmaceuticals

gainify

C

CStone Pharmaceuticals

2616

CStone Pharmaceuticals, a biopharmaceutical company, researches, develops, and commercializes immuno-oncology and precision medicines to address the unmet medical needs of cancer patients in China and internationally. It offers Sugemalimab, a monoclonal antibody again...

Sector

Healthcare

Industry

Biotechnology

CEO

Yang, Jianxin

Employees

93

IPO Date

2019-02-26

Headquarters

C1 Building, 218 Xinghu Street, North Block, Suzhou Industrial Park, Suzhou, Jiangsu Province, 215123, China

gainifypowered-by-sp
Socials
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on TrustpilotFollow us on YouTubeFind us on Google Maps

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2025 Gainify. All rights reserved.